Independent Research advice for BB Biotech
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| April 17, 2014 | Independent Research | BB Biotech | Buy | 140.00 CHF | -105.71 % |
Advice details
Frankfurt - Op 17 Apr 2014 (her)starten de analisten van Independent Research met het volgen van BB Biotech (ISIN: CH0038389992 / Mnemo: BBZ) met een koopadvies. Het 12-maands koersdoel is vastgesteld op 140.0 CHF
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 